MG
HOLX

Marex Group’s Hologic HOLX Stock Holding History

Marex Group’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,842
Closed -$232K – 751
2024
Q3 		$232K Buy
+2,842
New +$227K 0.01% 440

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marex Group's HOLX Position: Q4 2024 in Review

Marex Group sold out of Hologic (HOLX) in Q4 2024, closing a stake of 2,842 shares — an estimated $232K sold.

Marex Group first reported a position in HOLX in Q3 2024 and held it in 1 quarter. The position peaked at $232K in Q3 2024. 718 funds tracked by Wall St. Rank hold HOLX as of Q4 2024.

  • Marex Group reported no remaining Hologic position as of Q4 2024 after selling out during the quarter.
  • Marex Group sold 2,842 Hologic shares in Q4 2024, an estimated $232K.
  • Marex Group first reported a position in Hologic in Q3 2024 and held it in 1 quarter.
  • Marex Group's Hologic position peaked at $232K in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Hologic as of Q4 2024.

Based on Marex Group's 13F filing for Q4 2024, filed 2 Apr 2026.